KDM5C and intrahepatic cholangiocarcinoma: While, Zhang et al. recently reported that KDM5C was downregulated in intrahepatic cholangiocarcinoma cells (ICC), and its expression and function were required for inhibition of ICC proliferation and invasion and tumor repression through negatively regulating the expression of FASN [45].